<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="In-Process" Owner="NLM">        <PMID Version="1">30115017</PMID>        <DateRevised>            <Year>2018</Year>            <Month>08</Month>            <Day>21</Day>        </DateRevised>        <Article PubModel="Electronic">            <Journal>                <ISSN IssnType="Electronic">1471-2407</ISSN>                <JournalIssue CitedMedium="Internet">                    <Volume>18</Volume>                    <Issue>1</Issue>                    <PubDate>                        <Year>2018</Year>                        <Month>Aug</Month>                        <Day>16</Day>                    </PubDate>                </JournalIssue>                <Title>BMC cancer</Title>                <ISOAbbreviation>BMC Cancer</ISOAbbreviation>            </Journal>            <ArticleTitle>Lesions of &quot;uncertain malignant potential&quot; in the breast (B3) identified with mammography screening.</ArticleTitle>            <Pagination>                <MedlinePgn>829</MedlinePgn>            </Pagination>            <ELocationID EIdType="doi" ValidYN="Y">10.1186/s12885-018-4742-6</ELocationID>            <Abstract>                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Core needle biopsy (CNB) is a standard diagnostic procedure in the setting of breast cancer screening. However, CNB may result in the borderline diagnoses of lesion of uncertain malignant potential (B3). The aim of this study was to access the outcome of lesions diagnosed as B3 category in a large series of screen-detected cases to evaluate the rates of malignancy for the different histological subtypes.</AbstractText>                <AbstractText Label="METHODS" NlmCategory="METHODS">We identified all CNBs over a six-year period (2009-2015) in a breast cancer screening unit in Germany. A total of 8.388 CNB's were performed for screen detected breast lesions. B3 diagnosis comprised 4.5% (376/8.388). Of the 376 patients who were diagnosed as B3, 299 underwent subsequent excision biopsy with final excision histology.</AbstractText>                <AbstractText Label="RESULTS" NlmCategory="RESULTS">Out of 376 patients diagnosed with B3 lesions, the prevalence of different histopathology showed 161 (42.8%) patients with atypical ductal hyperplasia (ADH), 98 (26.1%) with flat epithelial atypia (FEA), 50 women (13.3%) showed lobular neoplasia (LN), in 40 (10.6%) patients papillary findings and in 27 patients (7.2%) a radial scar complex. Final excision histology was benign in 74% (221/299) and malignant in 26% (78/299) of the patients. Lesion specific positive predictive values (PPV) for a subsequent diagnosis of in situ or invasive carcinoma were as follows: ADH 40%, FEA 20.5%, papillary lesion 13.5%, radial scar 16.6%, LN 0%.</AbstractText>                <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Our results show that approximately one-third of core needle biopsies of screen detected breast lesions classified as B3 are premalignant or malignant on excision. Lesions of uncertain malignant potential of the breast (B3) are heterogeneous in respect to risk of malignancy.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Richter-Ehrenstein</LastName>                    <ForeName>Christiane</ForeName>                    <Initials>C</Initials>                    <Identifier Source="ORCID">http://orcid.org/0000-0001-7490-6719</Identifier>                    <AffiliationInfo>                        <Affiliation>Department of Gynaecology and Obstetrics, Breast Unit, Klinikum Frankfurt (Oder), Müllroser Chaussee 7, 15236, Frankfurt (Oder), Germany. christiane.richter-ehrenstein@klinikumffo.de.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Maak</LastName>                    <ForeName>Katharina</ForeName>                    <Initials>K</Initials>                    <AffiliationInfo>                        <Affiliation>Mammography Screening Unit Brandenburg Sued, Thiemstrasse 112, 03050, Cottbus, Germany.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Röger</LastName>                    <ForeName>Sonja</ForeName>                    <Initials>S</Initials>                    <AffiliationInfo>                        <Affiliation>Mammography Screening Unit Brandenburg Sued, Thiemstrasse 112, 03050, Cottbus, Germany.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Ehrenstein</LastName>                    <ForeName>Tilman</ForeName>                    <Initials>T</Initials>                    <AffiliationInfo>                        <Affiliation>Mammography Screening Unit Brandenburg Nord, Breitscheidstr.52, 16321, Bernau, Germany.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>08</Month>                <Day>16</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>England</Country>            <MedlineTA>BMC Cancer</MedlineTA>            <NlmUniqueID>100967800</NlmUniqueID>            <ISSNLinking>1471-2407</ISSNLinking>        </MedlineJournalInfo>        <CommentsCorrectionsList>            <CommentsCorrections RefType="Cites">                <RefSource>Ann Surg Oncol. 2011 Feb;18(2):463-7</RefSource>                <PMID Version="1">20878246</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Pathol. 2009 Dec;62(12):1136-40</RefSource>                <PMID Version="1">19946101</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Am J Surg Pathol. 2015 Jun;39(6):779-85</RefSource>                <PMID Version="1">25634748</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Histopathology. 2016 Jan;68(1):138-51</RefSource>                <PMID Version="1">26768035</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Ann Surg. 2012 Feb;255(2):259-65</RefSource>                <PMID Version="1">21989373</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Rofo. 2011 Aug;183(8):743-8</RefSource>                <PMID Version="1">21506072</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>N Engl J Med. 2015 Jan 1;372(1):78-89</RefSource>                <PMID Version="1">25551530</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Pathol. 2007 Dec;60(12):1300-6</RefSource>                <PMID Version="1">17630399</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast J. 2007 Jan-Feb;13(1):55-61</RefSource>                <PMID Version="1">17214794</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Ann Surg Oncol. 2013 Jan;20(1):94-101</RefSource>                <PMID Version="1">22878621</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Cancer. 2011 Sep 15;129(6):1417-24</RefSource>                <PMID Version="1">21128240</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Mayo Clin Proc. 2014 Apr;89(4):536-47</RefSource>                <PMID Version="1">24684875</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Histopathology. 2003 Apr;42(4):331-6</RefSource>                <PMID Version="1">12653944</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Br J Cancer. 2007 Apr 23;96(8):1253-7</RefSource>                <PMID Version="1">17438578</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Histopathology. 2010 Aug;57(2):171-92</RefSource>                <PMID Version="1">20500230</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>AJR Am J Roentgenol. 2008 Mar;190(3):637-41</RefSource>                <PMID Version="1">18287433</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Ann Surg Oncol. 2013 Jun;20(6):1900-5</RefSource>                <PMID Version="1">23314624</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast. 2007 Feb;16(1):94-101</RefSource>                <PMID Version="1">16982194</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Arch Pathol Lab Med. 2008 Jun;132(6):979-83</RefSource>                <PMID Version="1">18517282</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Histopathology. 2008 Dec;53(6):650-7</RefSource>                <PMID Version="1">19076681</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Hum Pathol. 2010 Apr;41(4):522-7</RefSource>                <PMID Version="1">20004938</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nat Rev Clin Oncol. 2015 Apr;12(4):227-38</RefSource>                <PMID Version="1">25622978</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Ann Surg Oncol. 2007 Feb;14(2):704-11</RefSource>                <PMID Version="1">17151788</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Ann Surg Oncol. 2012 Mar;19(3):914-21</RefSource>                <PMID Version="1">21861212</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Acta Radiol. 2016 Jul;57(7):815-21</RefSource>                <PMID Version="1">26552694</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Eur J Cancer. 2008 Nov;44(17):2580-6</RefSource>                <PMID Version="1">18632261</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer. 2013 Mar 1;119(5):1073-9</RefSource>                <PMID Version="1">23132235</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast J. 2013 Mar-Apr;19(2):130-3</RefSource>                <PMID Version="1">23336823</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res Treat. 2016 Sep;159(2):203-13</RefSource>                <PMID Version="1">27522516</PMID>            </CommentsCorrections>        </CommentsCorrectionsList>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">B3</Keyword>            <Keyword MajorTopicYN="N">Breast neoplasm</Keyword>            <Keyword MajorTopicYN="N">Mammography screening</Keyword>            <Keyword MajorTopicYN="N">Needle core biopsy</Keyword>            <Keyword MajorTopicYN="N">Positive predictive value</Keyword>        </KeywordList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="received">                <Year>2018</Year>                <Month>04</Month>                <Day>05</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="accepted">                <Year>2018</Year>                <Month>08</Month>                <Day>10</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>8</Month>                <Day>18</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>8</Month>                <Day>18</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>8</Month>                <Day>18</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>epublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30115017</ArticleId>            <ArticleId IdType="doi">10.1186/s12885-018-4742-6</ArticleId>            <ArticleId IdType="pii">10.1186/s12885-018-4742-6</ArticleId>            <ArticleId IdType="pmc">PMC6097423</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>